Double umbilical cord blood transplantation

Research output: Contribution to journalReview articlepeer-review

119 Scopus citations


Unrelated umbilical cord blood (UCB) is an alternative donor source for allogeneic haematopoietic cell transplantation and, compared with unrelated donor bone marrow, has the advantages of rapid availability, greater tolerance of HLA disparity and lower incidence of severe graft-versus-host disease. Graft cell dose is an important determinant of haematopoietic recovery and overall outcome following UCB transplantation, and the limited cell dose of single UCB units has been a major barrier to its more widespread use. Transplantation with two unrelated UCB units is feasible, safe and effective and can overcome the limitation of cell dose of single UCB units.

Original languageEnglish (US)
Pages (from-to)571-575
Number of pages5
JournalCurrent Opinion in Immunology
Issue number5
StatePublished - Oct 1 2006

Fingerprint Dive into the research topics of 'Double umbilical cord blood transplantation'. Together they form a unique fingerprint.

Cite this